The presence of tumor-infiltrating immune cells such as macrophages, CD8+ T-cells, T-reg, and NK-cells has been described in clinical samples [15,16,17,18] and associated with prognosis [17], imatinib response [15,19,20], and potential vulnerability to immune checkpoint inhibitors [21]. Here, CD8A is linked to neoplasm.